EuroPCR 2025

Discover innovative Shockwave Medical devices, idea-sparking educational sessions and more.

Innovation That Empowers

Please join us at EuroPCR as we continue to empower the future of cardiovascular care and transform lives around the world. This year’s event will include three days of valuable sessions at our Training Village where expert operators will deliver state-of-the-art presentations on how they solve everyday challenges with our two technologies, Shockwave IVL and Shockwave Reducer. In addition, our Hands-on Sessions will offer first-hand insights and tips and tricks for our innovative technologies.

We’ll also have two sponsored sessions where we’ll explore the mechanism of action and the benefits of Shockwave IVL and Shockwave Reducer.


Shockwave Training Village

The Shockwave Training Village is the best place to get up close and personal with Shockwave devices. Expert operators will demonstrate best practices using on-site models of Shockwave IVL and Shockwave Reducer, and you’ll have the opportunity to ask questions and dive deeper into how you can empower your own treatment algorithms.

NEW: Plus, for the first time ever, you’ll be able to get closer to Shockwave IVL than ever before thanks to an immersive virtual reality experience during “The Curious Case of Coronary Calcium: VR Case Presentation.” You won’t want to miss this exciting learning innovation.

See a session you like? Be sure to add it to your calendar!

Accordion Section

Hands-On Sessions

Sponsored Sessions

We’re passionate about ensuring you have the most up-to-date Shockwave IVL and Shockwave Reducer resources and data, and are excited to host two sponsored sessions at this year’s EuroPCR. Join us for exclusive insights on clinical practices, new clinical data and more.

Wednesday, 21 May | 12:30 – 14:00 | Room 242AB

Treat Calcium Right the First Time: New Considerations for PCI Planning & Device Selection to Optimize Outcomes

Join us for this symposium if you want to:

  • Learn with a real-world clinical case how to optimize treatment pathways for CAC, supported by new clinical data
  • Discuss the framework for selecting the most appropriate device for vessel prep, based on calcium burden, anatomical considerations and patient gender
  • Explore the role of Shockwave IVL as a first-line treatment strategy for managing coronary artery calcification and its impact on procedural outcomes

Featured Shockwave Symposium Speakers

This section contains attributions including profile pictures, titles, descriptions, and Twitter handles.

  • Prof. Emanuele Barbato
    Anchorperson, Sant’Andrea University Hospital – Rome, Italy
  • Dr. Angela McInerney
    Spokesperson, University Hospital Galway – Galway, Ireland
  • Dr. Javier Escaned
    Live Case Center, Hospital Clínico San Carlos – Madrid, Spain
  • Dr. Nieves Gonzalo
    Live Case Center, Hospital Clinico san Carlos – Madrid, Spain
  • Dr. Margaret McEntegart
    Discussant, Columbia University Medical Center – New York, United States
  • Dr. Marco Pavani
    Discussant, AOU San Luigi Gonzaga – Orbassano, Italy
  • Dr. Niels Tuhe Olsen
    Discussant, Rigshospitalet – Copenhagen, Denmark
  • Dr. Simon Wilson
    Discussant, St George’s University NHS Trust – London, United Kingdom

Shockwave Reducer Logo

Thursday, 22 May | 12:30 – 13:30 | Room 251

Road to Relief: Effective Treatment of Refractory Angina Patients with Shockwave Reducer

Join us for this symposium if you want to:

  • Understand the true impact and occurrence of refractory angina
  • Learn about the mechanism of action and implanting procedure of the Shockwave Reducer
  • Learn about both the clinical data and real-life examples supporting the efficacy of the Shockwave Reducer

Featured Shockwave Reducer Symposium Speakers

This section contains attributions including profile pictures, titles, descriptions, and Twitter handles.

  • Prof. James Spratt
    Anchorperson, St George’s University NHS Trust – London, United Kingdom
  • Dr. Felix Woitek
    Spokesperson, University Hospital Carl Gustav Carus Dresden Heart Center – Dresden, Germany
  • Dr. Ranil de Silva
    Discussant, Royal Brompton Hospital – London, United Kingdom
  • Prof. Tommaso Gori
    Discussant, University Medical Centre Johannes Gutenberg University Mainz – Mainz, Germany
  • Prof. Mariusz Tomaniak
    Discussant, Medical University of Warsaw – Warsaw, Poland

Late-Breaking Trials

Don’t miss the below session to learn more about EMPOWER CAD, Rollercoastr-EPIC22* and BALI late-breaking trials.

Tuesday, 20 May | 15:00 – 16:00 | Room 242AB

New Evidence for the Treatment of Calcified CAD

  • Anchorperson: M. Abdel-Wahab
  • Spokesperson: A. Low
  • Discussants: S. Gunasekaran, M. McEntegart, H. Nef, H. Noor

Scientific Sessions of Interest

Attend any of the following sessions for additional perspective and information.

Accordion Section

Featured Videos from EuroPCR 2024

*Rollercoastr-EPIC-22 is not a Shockwave Medical-sponsored study.

Physicians participating in the Training Village Sessions, Hands-on Sessions and Sponsored Sessions are paid consultants of Shockwave Medical.

Caution: In the United States, Shockwave Reducer is an investigational device, limited by United States law to investigational use. The Reducer is subject of Investigational testing and is being studied in the COSIRA-II trial in Canada.

Shockwave Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability. Prior to use, please reference the Instructions for Use for more information on warnings, precautions and adverse events: ifu.sw-reducer.com